Hong Kong Entertainment International Ltd. (8291)

Overview

Nextgen Biomed Ltd is a pioneering firm based in Tel Aviv, Israel, focused on the development of innovative topical treatments for psoriasis. Initially established in 1990 as Sela Group.Com Ltd., the company underwent a significant rebranding in February 2010, changing its name to Nextgen Biomed Ltd. This rebranding marked a milestone in the company's dedication to advancing biotechnological research and development for the betterment of individuals suffering from skin conditions, notably psoriasis. With decades of experience and a firm foundation in the biotech industry, Nextgen Biomed Ltd continues to push the boundaries of medical science, working towards novel therapeutic solutions.

Products and Services

Nextgen Biomed Ltd specializes in the development of a range of topical treatments aimed at addressing the complex challenges of psoriasis, a chronic skin condition that affects millions worldwide. Among its innovative solutions are:

• Advanced Topical Psoriasis Treatments: These are specially formulated creams or ointments designed to reduce the symptoms of psoriasis, such as itching, inflammation, and the formation of scaly skin patches. Leveraging cutting-edge research, these treatments aim to offer both relief and improvement in skin condition for patients.